CRM
ELAN icon

Cramer Rosenthal McGlynn’s Elanco Animal Health ELAN Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,706,225
Closed -$32.8M – 92
2024
Q4 		$32.8M Buy
2,706,225
+89,031
+3% +$1.16M 1.85% 15
2024
Q3 		$38.4M Buy
2,617,194
+1,618,778
+162% +$22.6M 2.13% 8
2024
Q2 		$14.4M Buy
998,416
+504,570
+102% +$8.06M 0.85% 50
2024
Q1 		$8.04M Buy
+493,846
New +$7.72M 0.44% 69

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cramer Rosenthal McGlynn's ELAN Position: Q1 2025 in Review

Cramer Rosenthal McGlynn sold out of Elanco Animal Health (ELAN) in Q1 2025, closing a stake of 2,706,225 shares — an estimated $32.8M sold.

Cramer Rosenthal McGlynn first reported a position in ELAN in Q1 2024 and held it in 4 quarters. The position peaked at $38.4M in Q3 2024. 364 funds tracked by Wall St. Rank hold ELAN as of Q1 2025.

  • Cramer Rosenthal McGlynn reported no remaining Elanco Animal Health position as of Q1 2025 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 2,706,225 Elanco Animal Health shares in Q1 2025, an estimated $32.8M.
  • Cramer Rosenthal McGlynn first reported a position in Elanco Animal Health in Q1 2024 and held it in 4 quarters.
  • Cramer Rosenthal McGlynn's Elanco Animal Health position peaked at $38.4M in Q3 2024.
  • 364 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2025.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2025, filed 14 May 2025.